Skip to main content

Table 1 Baseline characteristics of the participants according to the risk of short telomeres

From: Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial

 

Non-Risk of Short telomeres

(n = 356)

Risk of Short telomeres

(n = 87)

 

Non-T2DM (n = 279)

Incident-T2DM (n = 77)

p-value

Non-T2DM (n = 59)

Incident-T2DM (n = 28)

p-value

Men/Women (n)

235/44

62/15

0.288

53/6

24/4

0.574

LowFat/MeDiet (%)

50/50

38/62

0.054

39/61

46/54

0.510

Age (years)

57.25 ± 0.55

59.20 ± 1.07

0.103

57.66 ± 1.37

58.42 ± 1.47

0.731

Weight (kg)

82.21 ± 0.76

85.33 ± 1.84

0.075

82.82 ± 1.90

86.63 ± 2.36

0.239

BMI (kg/m2)

29.84 ± 0.24

31.45 ± 0.58

0.004

29.59 ± 0.57

31.38 ± 0.76

0.070

WC (cm)

101.12 ± 0.62

105 ± 1.36

0.005

103.63 ± 1.47

106.22 ± 1.77

0.295

HDL-c (mmol/L)

44.19 ± 0.59

45.36 ± 1.31

0.384

46.29 ± 1.27

38.41 ± 1.21

< 0.001

LDL-c (mmol/L)

91.12 ± 1.49

96.48 ± 3.42

0.115

91.24 ± 3.39

86.22 ± 3.65

0.3734

hsCRP (nmol/L)

2.38 ± 0.21

2.79 ± 0.32

0.335

3.04 ± 0.51

3.08 ± 0.67

0.954

Triglycerides (mmol/L)

118.56 ± 3.61

133.51 ± 8.02

0.066

122.54 ± 7.98

124.93 ± 10.87

0.863

HbA1c (%)

5.85 ± 0.02

6.02 ± 0.04

< 0.001

5.85 ± 0.04

6.05 ± 0.07

0.014

Glucose (mmol/L)

92.41 ± 0.60

95.46 ± 1.22

0.021

92.92 ± 1.21

98.0 ± 2.02

0.025

Insulin (nmol/L)

8.25 ± 0.35

10.43 ± 0.82

0.007

8.85 ± 0.70

11.24 ± 1.00

0.055

  1. Continuous variables are represented as means ± SE. Categorical variables are expressed as percentage. Variables were compared using the analysis t-test. Bold p-values denote statistical significance (p-value<0.050)
  2. Abbreviations BMI Body Mass Index; WC, Waist Circumference; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; hsCRP, high sensitive C reactive protein; HbA1c, hemoglobin A1c